Skip to main content

MenQuadfi Dosage

Generic name: NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN 10ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN 10ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN 10ug in 0.5mL, NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN 10ug in 0.5mL
Dosage form: solution for intramuscular injection

Medically reviewed by Drugs.com. Last updated on Jun 30, 2023.

Preparation for Administration

MenQuadfi is a clear, colorless solution.

Parenteral drug products should be inspected visually for particulate matter and/or discoloration prior to administration, whenever solution and container permit. If any of these conditions exist, the vaccine should not be administered. Discard the vial with any unused portion.

Dose and Schedule

Administer MenQuadfi as a single 0.5 mL injection intramuscularly.

Primary Vaccination

  • Individuals 2 years of age and older receive a single dose.

Booster Vaccination

  • A single dose of MenQuadfi may be administered to individuals 13 years of age and older who are at continued risk for meningococcal disease if at least 3 years have elapsed since a prior dose of meningococcal (groups A, C, W, Y) conjugate vaccine.

Vaccination Following Prior Dose of Meningococcal Polysaccharide Vaccine

  • A single dose of MenQuadfi may be administered if at least 3 years have elapsed since a prior dose of meningococcal polysaccharide vaccine.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.